Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Res Microbiol ; 153(2): 81-8, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11900267

RESUMO

In this investigation, 94 clinical isolates of Mycobacterium tuberculosis obtained over a 3-year period (1996-1998) from French Guiana were characterized by spoligotyping and IS6110-RFLP and the patterns obtained were compared with genotypes representing the worldwide diversity in an international spoligotyping database (n = 4269) and a IS6110-RFLP database (n = 4189). All the clustered isolates giving < or = 6 copies of IS6110 were further typed using the double-repetitive element (DRE)-PCR. The results obtained underlined the highly diverse nature of the M. tuberculosis population in French Guiana with potential links to neighboring countries within the Americas. It may be hypothesized that the genetic heterogeneity of tubercle bacilli in French Guiana is linked to the high number of imported cases of tuberculosis, that may account for as high as 68% of all tuberculosis cases. Although an epidemiological investigation based on direct interrogation of patients was not performed, available medical records suggested that the clustering of isolates was mostly linked to the following risk factors: pulmonary tuberculosis, smear-positive samples, foreign-born nationals and/or immigrants, and a high rate of HIV-TB coinfection. Thus the persisting foci of endemic disease and increased active transmission due to high population flux and HIV coinfection may be largely responsible for the relatively high incidence of tuberculosis in French Guiana.


Assuntos
Elementos de DNA Transponíveis/genética , Mycobacterium tuberculosis/classificação , Oligonucleotídeos/análise , Polimorfismo de Fragmento de Restrição , Tuberculose Pulmonar/epidemiologia , Adulto , Antituberculosos/farmacologia , Técnicas de Tipagem Bacteriana , Criança , Bases de Dados Factuais , Emigração e Imigração , Feminino , Guiana Francesa/epidemiologia , Humanos , Cooperação Internacional , Masculino , Testes de Sensibilidade Microbiana , Mycobacterium tuberculosis/efeitos dos fármacos , Mycobacterium tuberculosis/genética , Reação em Cadeia da Polimerase , Sequências Repetitivas de Ácido Nucleico , Tuberculose Pulmonar/microbiologia , Tuberculose Pulmonar/transmissão
2.
Am J Trop Med Hyg ; 69(4): 447-9, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14640507

RESUMO

A public health program to prevent mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV-1) by treatment with nevirapine has been ongoing in Yaounde, Cameroon since January 2000. After 24 months, plasma samples from 119 children born to HIV-1-positive mothers were tested for HIV-1 RNA between six and eight weeks after birth. Thirteen (10.9%) tested positive (95% confidence interval = 5.2-16.7%). Risk factors associated with MTCT in this study were maternal viral load (P < 0.05), low birth weight (chi2 for trend = 8.78, P = 0.01), and birth during the second half of the year. A high correlation was repeatedly observed between rainfall in a given month and the risk of MTCT of HIV-1 in children born three months later (r = 0.634, P < 0.001). Although we cannot rule out other tropical infections related to the rainy season, the role of malaria is highly suspected since the interval of three months we observed between the peaks of rainfall and the rate of transmission is consistent with the Plasmodium life cycle.


Assuntos
Infecções por HIV/epidemiologia , Infecções por HIV/transmissão , Transmissão Vertical de Doenças Infecciosas/estatística & dados numéricos , Complicações Infecciosas na Gravidez/epidemiologia , RNA Viral/análise , Adulto , Peso ao Nascer , Camarões/epidemiologia , Feminino , Infecções por HIV/sangue , Infecções por HIV/etiologia , HIV-1/genética , HIV-1/isolamento & purificação , Humanos , Lactente , Masculino , Gravidez , Complicações Infecciosas na Gravidez/sangue , Complicações Infecciosas na Gravidez/etiologia , Chuva , Fatores de Risco , Estações do Ano , Carga Viral
3.
J Med Microbiol ; 53(Pt 1): 47-50, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14663104

RESUMO

Eighteen reference strains of Chlamydia trachomatis were differentiated by omp1 PCR- and nested PCR-based RFLP analysis, using two restriction digestions, one with AluI and the other with the three enzymes HpaII, EcoRI and HinfI. AluI digestion allowed the differentiation of 12 different profiles after CT1/CT5 PCR and 13 different profiles after the nested PCR. The triple hydrolysis permitted the identification of 15 different patterns. In all, 16/18 reference strains were clearly identified. These reference patterns were successfully used to genotype 34 of 35 (28 strains and 7 clinical specimens) samples from infected students, collected during a screening programme in Yaounde (Cameroon). Genotypes D, Da, E, F, G and J were found. The most prevalent omp1 genotype was E (n = 14; 40 %), followed by F (n = 7; 20 %). As RFLP patterns of reference strains are essential for typing clinical isolates, they will greatly facilitate C. trachomatis characterization in many resource-limited laboratories.


Assuntos
Infecções por Chlamydia/microbiologia , Chlamydia trachomatis/genética , Doenças Urogenitais Femininas/microbiologia , Doenças Urogenitais Masculinas , Polimorfismo de Fragmento de Restrição , Porinas/genética , Camarões , Chlamydia trachomatis/classificação , Genótipo , Humanos , Reação em Cadeia da Polimerase , Mapeamento por Restrição
4.
J Med Virol ; 77(3): 390-8, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16173014

RESUMO

Hepatitis C virus infects humans world-wide. The virus genome varies greatly and it has several genotypes. HCV infection is highly prevalent in Central Africa and Cameroon. Initial studies on the genetic variability of HCV showed infection with HCV genotypes 1, 2, and 4. We have now sequenced the NS5b and E2 regions of 156 HCV isolates collected from patients presenting for diagnosis in Yaounde and used the data to describe the distribution of HCV genotypes and subtypes in patients with hepatitis in Cameroon. Genotype 1 was more frequent than Genotypes 4 and 2. Genotypes 1 and 4 were highly heterogeneous, containing many subtypes described previously (1b, 1c, 1e, 1h, 1l, 4f, 4t, 4p, 4k) and unsubtyped groups. There was a systematic phylogenetic concordance between NS5b and E2 sequence clustering. The Genotype 2 sequences did not vary. Neither subject age nor gender influenced HCV distribution. HCV Genotypes 1 and 4 are very heterogeneous in Cameroon, perhaps due to ancient infections. The homogeneity of HCV Genotype 2 indicates its more recent introduction from western Africa.


Assuntos
Hepacivirus/classificação , Hepacivirus/genética , Hepatite C/epidemiologia , Adulto , Idoso , Camarões/epidemiologia , Feminino , Variação Genética , Genótipo , Hepacivirus/isolamento & purificação , Hepatite C/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Filogenia , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Complicações Infecciosas na Gravidez/virologia , RNA Viral/sangue , Análise de Sequência de DNA , Proteínas do Envelope Viral/genética , Proteínas não Estruturais Virais/genética
5.
J Clin Microbiol ; 42(11): 5029-35, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15528691

RESUMO

A preliminary investigation of the genetic biodiversity of Mycobacterium tuberculosis complex strains in Cameroon, a country with a high prevalence of tuberculosis, described a group of closely related M. tuberculosis strains (the Cameroon family) currently responsible for more than 40% of smear-positive pulmonary tuberculosis cases. Here, we used various molecular methods to study the genetic characteristics of this family of strains. Cameroon family M. tuberculosis strains (i) are part of the major genetic group 2 and lack the TbD1 region like other families of epidemic strains, (ii) lack spacers 23, 24, and 25 in their direct repeat (DR) region, (iii) have an identical number of repeats in 8 of 12 variable-number tandem repeats of mycobacterial interspersed repetitive unit (MIRU-VNTR) loci, (iv) have similar IS6110-restriction fragment length polymorphism (RFLP) multiband patterns (10 to 15 copies) with seven common IS6110 bands, (v) do not have an IS6110 element in their DR locus, and (vi) have four IS6110 elements in open reading frames (adenylate cyclase, phospholipase C, moeY, and ATP binding genes). Analysis by spoligotyping, MIRU-VNTR, and IS6110-RFLP typing methods revealed differences not observed in previous studies; polymorphism as assessed by MIRU-VNTR typing was lower than suggested by spoligotyping, and in rare cases, strains with identical IS6110-RFLP patterns had spoligotypes differing by as much as 15 spacers. Our findings confirm the recent expansion of this family in Cameroon and indicate that the interpretation of molecular typing results has to be adapted to the characteristics of the strain population within each setting. The knowledge of this particular genotype, with its large involvement in tuberculosis in Cameroon, allows greater refinement of tuberculosis transmission studies by interpreting data in the context of this geographic area.


Assuntos
Técnicas de Tipagem Bacteriana , Mycobacterium tuberculosis/classificação , Mycobacterium tuberculosis/genética , Tuberculose Pulmonar/epidemiologia , Proteínas de Bactérias/genética , Camarões/epidemiologia , Elementos de DNA Transponíveis , Marcadores Genéticos/genética , Humanos , Repetições Minissatélites/genética , Mutagênese Insercional , Oligonucleotídeos/análise , Polimorfismo Genético , Polimorfismo de Fragmento de Restrição , Prevalência , Tuberculose Pulmonar/microbiologia
6.
J Med Virol ; 71(2): 219-25, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12938196

RESUMO

To determine the prevalence of hepatitis C virus (HCV) infection and genotype distribution in a rural isolated area of Central Africa, plasma of 409 Bantous (mean age, 32 years; range, 2-78 years) living in a remote village of the rain forest of Southern Cameroon was screened for anti-HCV antibodies. HCV seropositive samples were also subjected to qualitative detection of viral RNA. HCV antibodies were detected in 70 (17.1%) individuals, 48 (68.8%) of whom had detectable viremia. The seroprevalence did not differ by gender (P = 0.37), but increased significantly with age (P < 0.05), with a strong increase in the oldest age groups. Indeed, nearly one-half (48%) of the adults >50 years old were HCV seropositive. The characterization of the viral genotypes indicated that most of the HCV strains were of genotype 4 (76%), while genotype 2 (16%), and 1 (8%) were marginally represented. The results suggest a cohort effect with an old, possibly iatrogenic, group exposure rather than a continuous exposure. A more in-depth population-based epidemiological study is needed to address this issue further.


Assuntos
Hepacivirus/classificação , Hepacivirus/genética , Hepatite C/epidemiologia , População Rural , Adolescente , Adulto , Idoso , Camarões/epidemiologia , Criança , Pré-Escolar , Feminino , Genótipo , Hepacivirus/imunologia , Hepacivirus/isolamento & purificação , Hepatite C/virologia , Anticorpos Anti-Hepatite C/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Filogenia , RNA Viral/sangue , Análise de Sequência de DNA , Árvores , Viremia/epidemiologia , Viremia/virologia
7.
J Clin Microbiol ; 41(9): 4404-7, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12958277

RESUMO

The prevalence of Chlamydia trachomatis infection was 3.78% out of 1,277 volunteer students screened by direct fluorescence assay and Cobas Amplicor PCR. The infection was associated with the nonuse or inconsistent use of condoms in women (P = 0.026) and a previous sexually transmitted infection in men (P = 0.023). The most frequent genotypes determined by sequencing the omp1 genes of 25 clinical isolates were E (44%) and F (20%), and some strains harbored mutations, but E genotype strains did not.


Assuntos
Infecções por Chlamydia/epidemiologia , Chlamydia trachomatis/classificação , Adulto , Camarões/epidemiologia , Infecções por Chlamydia/diagnóstico , Infecções por Chlamydia/etiologia , Chlamydia trachomatis/isolamento & purificação , Feminino , Genótipo , Humanos , Masculino , Porinas/química , Porinas/genética , Prevalência , Fatores de Risco
8.
J Clin Microbiol ; 41(6): 2547-53, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12791879

RESUMO

We analyzed DNA polymorphisms in 455 Mycobacterium tuberculosis complex isolates from 455 patients to evaluate the biodiversity of tubercle bacilli in Ouest province, Cameroon. The phenotypic and genotypic identification methods gave concordant results for 99.5% of M. tuberculosis isolates (413 strains) and for 90% of Mycobacterium africanum isolates (41 strains). Mycobacterium bovis was isolated from only one patient. Analysis of regions of difference (RD4, RD9, and RD10) proved to be an accurate and rapid method of distinguishing between unusual members of the M. tuberculosis complex. Whereas M. africanum strains were the etiologic agent of tuberculosis in 56% of cases 3 decades ago, our results showed that these strains now account for just 9% of cases of tuberculosis. We identified a group of closely genetically related M. tuberculosis strains that are currently responsible for >40% of smear-positive pulmonary tuberculosis cases in this region of Cameroon. These strains shared a spoligotype lacking spacers 23, 24, and 25 and had highly related IS6110 ligation-mediated (LM) PCR patterns. They were designated the "Cameroon family." We did not find any significant association between tuberculosis-causing species or strain families and patient characteristics (sex, age, and human immunodeficiency virus status). A comparison of the spoligotypes of the Cameroon strains with an international spoligotype database (SpolDB3) containing 11,708 patterns from >90 countries, showed that the predominant spoligotype in Cameroon was limited to West African countries (Benin, Senegal, and Ivory Coast) and to the Caribbean area.


Assuntos
Mycobacterium tuberculosis/classificação , Mycobacterium/classificação , Polimorfismo Genético , Tuberculose Pulmonar/microbiologia , Camarões/epidemiologia , Elementos de DNA Transponíveis/genética , Genótipo , Humanos , Epidemiologia Molecular , Mycobacterium/genética , Mycobacterium tuberculosis/genética , Oligonucleotídeos/análise , Fenótipo , Reação em Cadeia da Polimerase/métodos , Tuberculose Pulmonar/epidemiologia
9.
J Med Virol ; 69(3): 384-90, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12526049

RESUMO

Central Africa is considered to be an area of high endemic hepatitis C infection. To determine the prevalence of anti-HCV antibodies, HCV RNA, and the genotype distribution in Cameroon, 1,494 pregnant women attending antenatal care units in Yaounde, Cameroon were screened for HCV infection. Anti-HCV antibodies were detected with a 3rd generation ELISA (Monolisa anti-HCV plus version 2, BioRad, Richmond, CA). All anti-HCV antibody-positive sera were then tested with another 3rd generation ELISA (AxSYM) HCV version 3, Abbott Laboratories, Abbott Park, IL) and subsequently for HCV RNA (Amplicor HCV, Roche Diagnostics, Basel, Switzerland). Genotype was determined by phylogenetic analysis of the NS5b gene. Seventy-three pregnant women were found to be anti-HCV antibody positive by the first ELISA, but only 28 were anti-HCV positive by both ELISA. The prevalence of anti-HCV antibodies was thus 1.9% (28/1,494) (95% CI: 1.3-2.7%). 21/28 (75%) of the positive samples by both ELISA were HCV RNA positive. The 45 samples that were HCV antibody negative by the second ELISA were also HCV RNA negative. The HCV subtypes identified were 1a (24%), 2f (38%) and 4f (38%). In contrast to previous studies, anti-HCV antibodies were rare among pregnant women in Cameroon. The percentage of HCV seropositive pregnant women who had circulating HCV RNA was similar to that observed in Europe. Several HCV genotypes were found in Cameroon.


Assuntos
Hepacivirus/classificação , Hepacivirus/isolamento & purificação , Hepatite C/epidemiologia , Complicações Infecciosas na Gravidez/epidemiologia , Viremia/epidemiologia , Adolescente , Adulto , Camarões/epidemiologia , Feminino , Genótipo , Hepacivirus/genética , Hepacivirus/fisiologia , Hepatite C/virologia , Anticorpos Anti-Hepatite C/sangue , Humanos , Filogenia , Gravidez , Complicações Infecciosas na Gravidez/virologia , Prevalência , RNA Viral/sangue , Proteínas não Estruturais Virais/genética , Viremia/virologia
10.
J Acquir Immune Defic Syndr ; 34(3): 274-80, 2003 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-14600571

RESUMO

OBJECTIVE: To determine the percentage of infected children for whom nevirapine (NVP) was used to prevent peripartum mother-to-child transmission (MTCT) of HIV in Yaoundé, Cameroon. DESIGN: The study was a prospective Public Health Pilot Program covering a 3-year period (January 2000-December 2002). METHODS: Counseled and consenting HIV-1-positive pregnant women were given a single dose of NVP at the onset of labor. Babies were given 2 mg/kg NVP syrup within the first 72 hours of life. NVP-treated children were regularly followed up and examined for HIV-1 infection at 6-8 weeks and 5-6 months through plasma viral load (VL) quantification with the bDNA system. RESULTS: One hundred twenty-three children were diagnosed with perinatal HIV-1 infection at 6-8 weeks and 5-6 months. Thirteen children (10.6% [13/123]; 95% confidence interval, 5.1-16) were infected and presented with high VLs, in general >500,000 copies/mL. Two children had intermediate VLs (between 50 and 3500 copies/mL) at both time points. One hundred seven children (87%) were considered not infected at 6-8 weeks of age. CONCLUSIONS: Our results indicate that the HIV-1 MTCT rate 6-8 weeks after NVP administration was not >13% (16/123), thus demonstrating the effectiveness of NVP for lowering the risk of HIV-1 MTCT in real-life settings.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Infecções por HIV/transmissão , HIV-1/isolamento & purificação , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Nevirapina/uso terapêutico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Complicações Infecciosas na Gravidez/virologia , Camarões/epidemiologia , Feminino , Infecções por HIV/epidemiologia , Infecções por HIV/prevenção & controle , HIV-1/genética , Humanos , Técnicas Imunoenzimáticas , Lactente , Projetos Piloto , Gravidez , Estudos Prospectivos , RNA Viral/sangue , Estatísticas não Paramétricas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA